{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:13:13Z","timestamp":1703203993081},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bunyaviruses constitute a large and diverse group of viruses encompassing many emerging pathogens, such as Rift Valley fever virus (family <jats:italic>Phenuiviridae<\/jats:italic>), with public and veterinary health relevance but with very limited medical countermeasures are available. For the development of antiviral strategies, the identification and validation of virus-specific targets would be of high value. The cap-snatching mechanism is an essential process in the life cycle of bunyaviruses to produce capped mRNAs, which are then recognized and translated into viral proteins by the host cell translation machinery. Cap-snatching involves cap-binding as well as endonuclease functions and both activities have been demonstrated to be druggable in related influenza viruses. Here, we explore the suitability of the phenuivirus cap-binding function as a target in medium- and high-throughput drug discovery approaches. We developed a range of in vitro assays aiming to detect the interaction between the cap-binding domain (CBD) and the analogue of its natural cap-ligand m<jats:sup>7<\/jats:sup>GTP. However, constricted by its shallow binding pocket and low affinity for m<jats:sup>7<\/jats:sup>GTP, we conclude that the CBD has limited small molecule targeting potential using classical in vitro drug discovery approaches.<\/jats:p>","DOI":"10.1038\/s41598-023-50158-5","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T08:02:21Z","timestamp":1703145741000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Limited high-throughput screening compatibility of the phenuivirus cap-binding domain"],"prefix":"10.1038","volume":"13","author":[{"given":"Janna","family":"Scherf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheraz","family":"Gul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette","family":"Reinshagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Gribbon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"50158_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/v3050493","volume":"3","author":"T Ikegami","year":"2011","unstructured":"Ikegami, T. & Makino, S. The pathogenesis of Rift Valley fever. Viruses 3, 493\u2013519 (2011).","journal-title":"Viruses"},{"key":"50158_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijid.2018.11.017","volume":"79","author":"C Chen","year":"2019","unstructured":"Chen, C. et al. Animals as amplification hosts in the spread of severe fever with thrombocytopenia syndrome virus: A systematic review and meta-analysis. Int. J. Infect. Dis. 79, 77\u201384 (2019).","journal-title":"Int. J. Infect. Dis."},{"issue":"5","key":"50158_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s12276-021-00610-1","volume":"53","author":"MA Casel","year":"2021","unstructured":"Casel, M. A., Park, S. J. & Choi, Y. K. Severe fever with thrombocytopenia syndrome virus: Emerging novel phlebovirus and their control strategy. Exp. Mol. Med. 53(5), 713\u2013722 (2021).","journal-title":"Exp. Mol. Med."},{"key":"50158_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11262-018-1611-y","volume":"55","author":"NN Gaudreault","year":"2019","unstructured":"Gaudreault, N. N. et al. Molecular aspects of Rift Valley fever virus and the emergence of reassortants. Virus genes 55, 1\u201311 (2019).","journal-title":"Virus genes"},{"key":"50158_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","volume":"159","author":"MS Mehand","year":"2018","unstructured":"Mehand, M. S., Al-Shorbaji, F., Millett, P. & Murgue, B. The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. Antivir. Res. 159, 63\u201367 (2018).","journal-title":"Antivir. Res."},{"key":"50158_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.virusres.2017.01.018","volume":"234","author":"F Ferron","year":"2017","unstructured":"Ferron, F., Weber, F., de la Torre, J. C. & Reguera, J. Transcription and replication mechanisms of Bunyaviridae and Arenaviridae L proteins. Virus Res. 234, 118\u2013134 (2017).","journal-title":"Virus Res."},{"key":"50158_CR7","doi-asserted-by":"publisher","first-page":"e1007829","DOI":"10.1371\/journal.ppat.1007829","volume":"15","author":"N Gogrefe","year":"2019","unstructured":"Gogrefe, N., Reindl, S., G\u00fcnther, S. & Rosenthal, M. Structure of a functional cap-binding domain in Rift Valley fever virus L protein. PLoS Pathog. 15, e1007829 (2019).","journal-title":"PLoS Pathog."},{"key":"50158_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tim.2019.12.006","volume":"28","author":"S Olschewski","year":"2020","unstructured":"Olschewski, S., Cusack, S. & Rosenthal, M. The cap-snatching mechanism of bunyaviruses. Trends Microbiol. 28, 293\u2013303 (2020).","journal-title":"Trends Microbiol."},{"key":"50158_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.tim.2018.12.013","volume":"27","author":"AP Walker","year":"2019","unstructured":"Walker, A. P. & Fodor, E. Interplay between influenza virus and the host RNA polymerase II transcriptional machinery. Trends Microbiol. 27, 398\u2013407 (2019).","journal-title":"Trends Microbiol."},{"key":"50158_CR10","doi-asserted-by":"publisher","first-page":"5749","DOI":"10.1093\/nar\/gkaa253","volume":"48","author":"D Vogel","year":"2020","unstructured":"Vogel, D. et al. Structural and functional characterization of the severe fever with thrombocytopenia syndrome virus L protein. Nucleic Acids Res. 48, 5749\u20135765 (2020).","journal-title":"Nucleic Acids Res."},{"key":"50158_CR11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0092-8674(00)80280-9","volume":"89","author":"J Marcotrigiano","year":"1997","unstructured":"Marcotrigiano, J., Gingras, A. C., Sonenberg, N. & Burley, S. K. Cocrystal structure of the messenger RNA 5\u2032 cap-binding protein (eIF4E) bound to 7-methyl-GDP. Cell 89, 951\u2013961 (1997).","journal-title":"Cell"},{"key":"50158_CR12","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1093\/emboj\/cdf538","volume":"21","author":"C Mazza","year":"2002","unstructured":"Mazza, C., Segref, A., Mattaj, I. W. & Cusack, S. Large-scale induced fit recognition of an m7G pppG cap analogue by the human nuclear cap-binding complex. EMBO J. 21, 5548 (2002).","journal-title":"EMBO J."},{"key":"50158_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1097-2765(00)80044-1","volume":"1","author":"AE Hodel","year":"1998","unstructured":"Hodel, A. E., Gershon, P. D. & Quiocho, F. A. Structural basis for sequence-nonspecific recognition of 5\u2032-capped mRNA by a cap-modifying enzyme. Mol. Cell 1, 443\u2013447 (1998).","journal-title":"Mol. Cell"},{"key":"50158_CR14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1021\/acsmedchemlett.6b00486","volume":"8","author":"LJ Farmer","year":"2017","unstructured":"Farmer, L. J. et al. Discovery of novel, orally bioavailable \u03b2-Amino acid azaindole inhibitors of influenza PB2. ACS Med. Chem. Lett. 8, 256\u2013260 (2017).","journal-title":"ACS Med. Chem. Lett."},{"key":"50158_CR15","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.drudis.2022.02.024","volume":"27","author":"W Chen","year":"2022","unstructured":"Chen, W., Shao, J., Ying, Z., Du, Y. & Yu, Y. Approaches for discovery of small-molecular antivirals targeting to influenza A virus PB2 subunit. Drug Discov. Today 27, 1545\u20131553 (2022).","journal-title":"Drug Discov. Today"},{"key":"50158_CR16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3390\/molecules26041007","volume":"26","author":"J Gregor","year":"2021","unstructured":"Gregor, J. et al. Structural and thermodynamic analysis of the resistance development to pimodivir (VX-787), the clinical inhibitor of cap binding to PB2 subunit of influenza A polymerase. Molecules 26, 1007 (2021).","journal-title":"Molecules"},{"key":"50158_CR17","unstructured":"A study to evaluate the efficacy and safety of pimodivir in combination with the standard-of-care treatment in adolescent, adult, and elderly hospitalized participants with influenza A infection\u2014Study results\u2014ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT03376321."},{"key":"50158_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/sj.bjc.6603509","volume":"96","author":"C Benson","year":"2007","unstructured":"Benson, C. et al. A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days. Br. J. Cancer 96, 29\u201337 (2007).","journal-title":"Br. J. Cancer"},{"key":"50158_CR19","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1016\/j.ejca.2010.08.001","volume":"46","author":"C Le Tourneau","year":"2010","unstructured":"Le Tourneau, C. et al. Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies. Eur. J. Cancer 46, 3243\u20133250 (2010).","journal-title":"Eur. J. Cancer"},{"key":"50158_CR20","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bbrc.2020.04.034","volume":"526","author":"Q Huang","year":"2020","unstructured":"Huang, Q. et al. Kinase inhibitor roscovitine as a PB2 cap-binding inhibitor against influenza a virus replication. Biochem. Biophys. Res. Commun. 526, 1143\u20131149 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"50158_CR21","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1021\/cr900267p","volume":"110","author":"DM Jameson","year":"2010","unstructured":"Jameson, D. M. & Ross, J. A. Fluorescence polarization\/anisotropy in diagnostics and imaging. Chem. Rev. 110, 2685\u20132708 (2010).","journal-title":"Chem. Rev."},{"key":"50158_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0022-2836(02)00328-5","volume":"319","author":"A Niedzwiecka","year":"2002","unstructured":"Niedzwiecka, A. et al. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5\u2032 cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins. J. Mol. Biol. 319, 615\u2013635 (2002).","journal-title":"J. Mol. Biol."},{"key":"50158_CR23","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1128\/AAC.04623-14","volume":"59","author":"RA Byrn","year":"2015","unstructured":"Byrn, R. A. et al. Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit. Antimicrob. Agents Chemother. 59, 1569\u20131582 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"50158_CR24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00249-021-01529-1","volume":"50","author":"B L\u00f3pez-M\u00e9ndez","year":"2021","unstructured":"L\u00f3pez-M\u00e9ndez, B., Uebel, S., Lundgren, L. P. & Sedivy, A. Microscale Thermophoresis and additional effects measured in NanoTemper Monolith instruments. Eur. Biophys. J. 50, 653\u2013660 (2021).","journal-title":"Eur. Biophys. J."},{"key":"50158_CR25","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1107\/S2059798321008998","volume":"77","author":"O Burastero","year":"2021","unstructured":"Burastero, O. et al. eSPC: An online data-analysis platform for molecular biophysics. Acta Crystallogr. Sect. D Struct. Biol. 77, 1241\u20131250 (2021).","journal-title":"Acta Crystallogr. Sect. D Struct. Biol."},{"key":"50158_CR26","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41467-022-28428-z","volume":"13","author":"B Arragain","year":"2022","unstructured":"Arragain, B. et al. Structural snapshots of La Crosse virus polymerase reveal the mechanisms underlying Peribunyaviridae replication and transcription. Nat. Commun. 13, 902 (2022).","journal-title":"Nat. Commun."},{"key":"50158_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41594-019-0232-z","volume":"26","author":"T Kouba","year":"2019","unstructured":"Kouba, T., Drncov\u00e1, P. & Cusack, S. Structural snapshots of actively transcribing influenza polymerase. Nat. Struct. Mol. Biol. 26, 460\u2013470 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"50158_CR28","doi-asserted-by":"publisher","DOI":"10.1101\/2023.11.29.569195","author":"HM Williams","year":"2023","unstructured":"Williams, H. M. et al. Structural snapshots of phenuivirus cap-snatching and transcription. bioRxiv https:\/\/doi.org\/10.1101\/2023.11.29.569195 (2023).","journal-title":"bioRxiv"},{"key":"50158_CR29","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/nar\/gkac1249","volume":"51","author":"HM Williams","year":"2023","unstructured":"Williams, H. M. et al. Structural insights into viral genome replication by the severe fever with thrombocytopenia syndrome virus L protein. Nucleic Acids Res. 51, 1424\u20131442 (2023).","journal-title":"Nucleic Acids Res."},{"key":"50158_CR30","doi-asserted-by":"publisher","first-page":"e1011060","DOI":"10.1371\/journal.ppat.1011060","volume":"19","author":"H Malet","year":"2023","unstructured":"Malet, H., Williams, H. M., Cusack, S. & Rosenthal, M. The mechanism of genome replication and transcription in bunyaviruses. PLoS Pathog. 19, e1011060 (2023).","journal-title":"PLoS Pathog."},{"key":"50158_CR31","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1177\/1087057106292746","volume":"11","author":"MD Cummings","year":"2006","unstructured":"Cummings, M. D., Farnum, M. A. & Nelen, M. I. Universal screening methods and applications of ThermoFluor\u00ae. SLAS Discov. 11, 854\u2013863 (2006).","journal-title":"SLAS Discov."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50158-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50158-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50158-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T08:11:37Z","timestamp":1703146297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50158-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["50158"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-50158-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"29 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22820"}}